Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Jul 31, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 38
- +5 vs. Q1 2025
- Portfolio value
- $305.9M
- −$6.25M (−2.0%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PFEPfizer Inc | Stock | 920,000 | $22.3M | 7.3% | −5,000−0.5% | Reduced | History |
| MDTMedtronic plc | Stock | 224,000 | $19.5M | 6.4% | +19,000+9.3% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 406,000 | $18.8M | 6.1% | −29,000−6.7% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 98,000 | $16.9M | 5.5% | +16,000+19.5% | Added | History |
| MRKMerck & Co., Inc. | Stock | 202,000 | $16.0M | 5.2% | +202,000 | New | History |
| GILDGilead Sciences, Inc. | Stock | 127,000 | $14.1M | 4.6% | −13,000−9.3% | Reduced | History |
| INCYIncyte Corp | COM | 204,000 | $13.9M | 4.5% | +45,000+28.3% | Added | History |
| AMGNAmgen Inc | Stock | 44,000 | $12.3M | 4.0% | −15,000−25.4% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 285,842 | $11.3M | 3.7% | 00.0% | Unchanged | History |
| CVSCVS Health Corp | Stock | 163,000 | $11.2M | 3.7% | −39,000−19.3% | Reduced | History |
| CAHCardinal Health Inc | Stock | 66,000 | $11.1M | 3.6% | −22,000−25.0% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 25,500 | $10.3M | 3.4% | +25,500 | New | History |
| CNCCentene Corp | Stock | 152,000 | $8.25M | 2.7% | −25,000−14.1% | Reduced | History |
| BAXBaxter International Inc | Stock | 268,007 | $8.12M | 2.7% | +20,357+8.2% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 88,631 | $8.08M | 2.6% | −25,000−22.0% | Reduced | History |
| BRKRBruker Corp | COM | 195,970 | $8.07M | 2.6% | −16,000−7.5% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 18,779 | $7.30M | 2.4% | −10,000−34.7% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 122,348 | $6.73M | 2.2% | −15,000−10.9% | Reduced | History |
| BIIBBiogen Inc. | COM | 50,639 | $6.36M | 2.1% | +32,000+171.7% | Added | History |
| HUMHumana Inc | Stock | 23,500 | $5.75M | 1.9% | −1,500−6.0% | Reduced | History |
| QGENQiagen N.V. | COMMON STOCK | 117,000 | $5.62M | 1.8% | −70,000−37.4% | Reduced | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 74,000 | $5.48M | 1.8% | +12,000+19.4% | Added | History |
| LHLabcorp Holdings Inc. | Stock | 19,484 | $5.11M | 1.7% | +19,484 | New | History |
| AVTRAvantor, Inc. | COM | 372,638 | $5.02M | 1.6% | +372,638 | New | History |
| PTCTPTC Therapeutics, Inc. | COM | 92,250 | $4.51M | 1.5% | 00.0% | Unchanged | History |
| DXCMDexcom Inc | COM | 50,000 | $4.36M | 1.4% | +50,000 | New | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 17,829 | $4.30M | 1.4% | +4,000+28.9% | Added | History |
| ELANElanco Animal Health Inc | COM | 292,073 | $4.17M | 1.4% | −185,000−38.8% | Reduced | History |
| LNTHLantheus Holdings, Inc. | Stock | 50,301 | $4.12M | 1.3% | +25,301+101.2% | Added | History |
| BNTXBioNTech SE | SPONSORED ADS | 37,470 | $3.99M | 1.3% | +7,470+24.9% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 210,523 | $3.92M | 1.3% | +30,000+16.6% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 42,000 | $3.28M | 1.1% | −81,000−65.9% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 8,000 | $3.06M | 1.0% | +8,000 | New | History |
| TGTXTG Therapeutics, Inc. | COM | 82,000 | $2.95M | 1.0% | +27,000+49.1% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 17,000 | $2.93M | 1.0% | 00.0% | Unchanged | History |
| SOLVSolventum Corp | Stock | 38,000 | $2.88M | 0.9% | +8,000+26.7% | Added | History |
| THCTenet Healthcare Corp | COM NEW | 12,500 | $2.20M | 0.7% | −30,500−70.9% | Reduced | History |
| ACLXArcellx, Inc. | COMMON STOCK | 25,000 | $1.65M | 0.5% | −10,000−28.6% | Reduced | History |
Sold out since Q1 2025 (1)
Positions held at the end of Q1 2025 that are gone from this filing.